Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

"Deciphering Steroid Receptor Crosstalk in Hormone-Driven Cancers".

Truong TH, Lange CA.

Endocrinology. 2018 Oct 10. doi: 10.1210/en.2018-00831. [Epub ahead of print]

PMID:
30307542
2.

NOTCH3 expression is linked to breast cancer seeding and distant metastasis.

Leontovich AA, Jalalirad M, Salisbury JL, Mills L, Haddox C, Schroeder M, Tuma A, Guicciardi ME, Zammataro L, Gambino MW, Amato A, Di Leonardo A, McCubrey J, Lange CA, Liu M, Haddad T, Goetz M, Boughey J, Sarkaria J, Wang L, Ingle JN, Galanis E, D'Assoro AB.

Breast Cancer Res. 2018 Sep 4;20(1):105. doi: 10.1186/s13058-018-1020-0.

3.

Increased expression of hypoxia-inducible factor-1 alpha and its impact on transcriptional changes and prognosis in malignant tumours of the ocular adnexa.

Lange CAK, Lehnert P, Boneva SK, Zhang P, Ludwig F, Boeker M, Hoffmeier K, Horres R, Schlunck G, Reinhard T, Böhringer D, Auw-Haedrich C.

Eye (Lond). 2018 Nov;32(11):1772-1782. doi: 10.1038/s41433-018-0172-6. Epub 2018 Jul 31.

4.

The interobserver agreement in the detection of recurrent HNSCC using MRI including diffusion weighted MRI.

Peltenburg B, Driessen JP, Philippens MEP, Pameijer FA, Castelijns J, Dankbaar JW, Dorgelo B, Lange CAH, Meijer FJA, Palm WM, Roosendaal SD, Steens SCA, Verbist BM, Stegeman I, Janssen LM, de Bree R, Terhaard CHJ.

Eur J Radiol. 2018 Aug;105:134-140. doi: 10.1016/j.ejrad.2018.05.031. Epub 2018 May 31.

PMID:
30017269
5.

Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.

Regan Anderson TM, Ma S, Perez Kerkvliet C, Peng Y, Helle TM, Krutilina RI, Raj GV, Cidlowski JA, Ostrander JH, Schwertfeger KL, Seagroves TN, Lange CA.

Mol Cancer Res. 2018 Nov;16(11):1761-1772. doi: 10.1158/1541-7786.MCR-18-0410. Epub 2018 Jul 10.

PMID:
29991529
6.

Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes.

Truong TH, Hu H, Temiz NA, Hagen KM, Girard BJ, Brady NJ, Schwertfeger KL, Lange CA, Ostrander JH.

Mol Cancer Res. 2018 Apr;16(4):707-719. doi: 10.1158/1541-7786.MCR-17-0598. Epub 2018 Jan 18.

PMID:
29348189
7.

Pathway-based discovery of genetic interactions in breast cancer.

Wang W, Xu ZZ, Costanzo M, Boone C, Lange CA, Myers CL.

PLoS Genet. 2017 Sep 28;13(9):e1006973. doi: 10.1371/journal.pgen.1006973. eCollection 2017 Sep.

8.

Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.

Leehy KA, Truong TH, Mauro LJ, Lange CA.

J Steroid Biochem Mol Biol. 2018 Feb;176:88-93. doi: 10.1016/j.jsbmb.2017.04.011. Epub 2017 Apr 23. Review.

PMID:
28442393
9.

Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.

Knutson TP, Truong TH, Ma S, Brady NJ, Sullivan ME, Raj G, Schwertfeger KL, Lange CA.

J Hematol Oncol. 2017 Apr 17;10(1):89. doi: 10.1186/s13045-017-0462-7.

10.

Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells.

Huang Y, Burns DJ, Rich BE, MacNeil IA, Dandapat A, Soltani SM, Myhre S, Sullivan BF, Lange CA, Furcht LT, Laing LG.

BMC Cancer. 2017 Mar 16;17(1):199. doi: 10.1186/s12885-017-3181-0.

11.

VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation.

Fantin A, Lampropoulou A, Senatore V, Brash JT, Prahst C, Lange CA, Liyanage SE, Raimondi C, Bainbridge JW, Augustin HG, Ruhrberg C.

J Exp Med. 2017 Apr 3;214(4):1049-1064. doi: 10.1084/jem.20160311. Epub 2017 Mar 13.

12.

Supine Breast MRI Using Respiratory Triggering.

Janssen NNY, Ter Beek LC, Loo CE, Winter-Warnars G, Lange CAH, van Loveren M, Alderliesten T, Sonke JJ, Nijkamp J.

Acad Radiol. 2017 Jul;24(7):818-825. doi: 10.1016/j.acra.2017.01.003. Epub 2017 Feb 27.

PMID:
28256441
13.

Editorial: Towards Improving the Science of Hormones and Cancer.

Lange CA.

Horm Cancer. 2017 Feb;8(1):1-3. doi: 10.1007/s12672-016-0281-2. No abstract available.

PMID:
28120150
14.

Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapy.

Hamming-Vrieze O, van Kranen SR, Heemsbergen WD, Lange CAH, van den Brekel MWM, Verheij M, Rasch CRN, Sonke JJ.

Radiother Oncol. 2017 Feb;122(2):224-228. doi: 10.1016/j.radonc.2016.10.012. Epub 2016 Nov 18.

PMID:
27866848
15.

Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort.

Bonneterre J, Bosq J, Jamme P, Valent A, Gilles EM, Zukiwski AA, Fuqua SA, Lange CA, O'Shaughnessy J.

ESMO Open. 2016 Aug 22;1(4):e000072. eCollection 2016.

16.

Value of Optical Coherence Tomography Angiography Imaging in Diagnosis and Treatment of Hemangioblastomas in von Hippel-Lindau Disease.

Lang SJ, Cakir B, Evers C, Ludwig F, Lange CA, Agostini HT.

Ophthalmic Surg Lasers Imaging Retina. 2016 Oct 1;47(10):935-946. doi: 10.3928/23258160-20161004-07.

PMID:
27759860
17.

A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity.

Huang Y, Burns DJ, Rich BE, MacNeil IA, Dandapat A, Soltani SM, Myhre S, Sullivan BF, Furcht LT, Lange CA, Hurvitz SA, Laing LG.

Oncotarget. 2016 Nov 29;7(48):78577-78590. doi: 10.18632/oncotarget.12480.

19.

Communication: Molecular gears.

Burnell EE, de Lange CA, Meerts WL.

J Chem Phys. 2016 Sep 7;145(9):091101. doi: 10.1063/1.4962221.

PMID:
27608981
20.

Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.

Leehy KA, Regan Anderson TM, Daniel AR, Lange CA, Ostrander JH.

J Mol Endocrinol. 2016 Apr;56(3):R99-R114. doi: 10.1530/JME-15-0322. Epub 2016 Feb 1. Review.

PMID:
26831511
21.

Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer.

Regan Anderson TM, Ma SH, Raj GV, Cidlowski JA, Helle TM, Knutson TP, Krutilina RI, Seagroves TN, Lange CA.

Cancer Res. 2016 Mar 15;76(6):1653-63. doi: 10.1158/0008-5472.CAN-15-2510. Epub 2016 Jan 29.

22.

Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.

Liyanage SE, Fantin A, Villacampa P, Lange CA, Denti L, Cristante E, Smith AJ, Ali RR, Luhmann UF, Bainbridge JW, Ruhrberg C.

Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):19-24. doi: 10.1161/ATVBAHA.115.306681. Epub 2015 Nov 24.

23.

Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.

Diep CH, Knutson TP, Lange CA.

Mol Cancer Res. 2016 Feb;14(2):141-62. doi: 10.1158/1541-7786.MCR-15-0431. Epub 2015 Nov 17.

24.

Tumor volume as a prognostic factor for local control and overall survival in advanced larynx cancer.

Timmermans AJ, Lange CA, de Bois JA, van Werkhoven E, Hamming-Vrieze O, Hilgers FJ, van den Brekel MW.

Laryngoscope. 2016 Feb;126(2):E60-7. doi: 10.1002/lary.25567. Epub 2015 Aug 29.

PMID:
26333005
25.

Minireview: Deciphering the Cellular Functions of PELP1.

Ravindranathan P, Lange CA, Raj GV.

Mol Endocrinol. 2015 Sep;29(9):1222-9. doi: 10.1210/me.2015-1049. Epub 2015 Jul 9. Review. No abstract available.

26.

Communication: molecular dynamics and (1)H NMR of n-hexane in liquid crystals.

Weber AC, Burnell EE, Meerts WL, de Lange CA, Dong RY, Muccioli L, Pizzirusso A, Zannoni C.

J Chem Phys. 2015 Jul 7;143(1):011103. doi: 10.1063/1.4923253.

PMID:
26156458
27.

Publisher's Note: "A model-free temperature-dependent conformational study of n-pentane in nematic liquid crystals" [J. Chem. Phys. 142, 024904 (2015)].

Burnell EE, Weber AC, Dong RY, Meerts WL, de Lange CA.

J Chem Phys. 2015 Feb 28;142(8):089901. doi: 10.1063/1.4913425. No abstract available.

PMID:
25725758
28.

A model-free temperature-dependent conformational study of n-pentane in nematic liquid crystals.

Burnell EE, Weber AC, Dong RY, Meerts WL, de Lange CA.

J Chem Phys. 2015 Jan 14;142(2):024904. doi: 10.1063/1.4904822. Erratum in: J Chem Phys. 2015 Feb 28;142(8):089901.

PMID:
25591384
29.

A bright future for Hormones and Cancer: farewell comments of Dr. Carol A. Lange, recent past Editor-in-Chief.

Lange CA.

Horm Cancer. 2015 Feb;6(1):5-6. doi: 10.1007/s12672-014-0212-z. No abstract available.

PMID:
25588986
30.

Progesterone action in breast, uterine, and ovarian cancers.

Diep CH, Daniel AR, Mauro LJ, Knutson TP, Lange CA.

J Mol Endocrinol. 2015 Apr;54(2):R31-53. doi: 10.1530/JME-14-0252. Epub 2015 Jan 13. Review.

31.

Statement of principle.

Cefalu WT, Nair KS, Seaquist ER, Zierath J, Boulton AJ, LeRoith D, Harrell RM, Grunberger G, Wartofsky L, Gore AC, Wierman ME, Hammes SR, Lange CA, Santen RJ.

Horm Cancer. 2015 Feb;6(1):1. doi: 10.1007/s12672-014-0206-x. No abstract available.

PMID:
25410830
32.

Statement of principle.

Cefalu WT, Nair KS, Seaquist ER, Zierath J, Boulton AJ, LeRoith D, Harrell RM, Grunberger G, Wartofsky L, Gore AC, Wierman ME, Hammes SR, Lange CA, Santen RJ.

Endocr Rev. 2014 Dec;35(6):850. doi: 10.1210/er.2014-1089. Epub 2014 Nov 3. No abstract available.

PMID:
25365740
33.

Statement of principle.

Cefalu WT, Nair KS, Seaquist ER, Zierath J, Boulton AJ, LeRoith D, Harrell RM, Grunberger G, Wartofsky L, Gore AC, Wierman ME, Hammes SR, Lange CA, Santen RJ.

J Clin Endocrinol Metab. 2014 Dec;99(12):4376. doi: 10.1210/jc.2014-3958. No abstract available.

PMID:
25365410
34.

Lost in translation: can we afford to miss the trees for the forest?

Hammes SR, Lange CA.

Horm Cancer. 2014 Aug;5(4):203-6. doi: 10.1007/s12672-014-0187-9. No abstract available.

PMID:
24980775
35.

Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor.

Bravo ML, Pinto MP, Gonzalez I, Oliva B, Kato S, Cuello MA, Lange CA, Owen GI.

Endocrine. 2015 Feb;48(1):309-20. doi: 10.1007/s12020-014-0288-9. Epub 2014 May 23.

PMID:
24853881
36.

Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.

Dressing GE, Knutson TP, Schiewer MJ, Daniel AR, Hagan CR, Diep CH, Knudsen KE, Lange CA.

Mol Endocrinol. 2014 Apr;28(4):442-57. doi: 10.1210/me.2013-1196. Epub 2014 Feb 25.

37.

Molecular determinants of context-dependent progesterone receptor action in breast cancer.

Hagan CR, Lange CA.

BMC Med. 2014 Feb 20;12:32. doi: 10.1186/1741-7015-12-32. Review.

38.

Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.

Daniel AR, Gaviglio AL, Knutson TP, Ostrander JH, D'Assoro AB, Ravindranathan P, Peng Y, Raj GV, Yee D, Lange CA.

Oncogene. 2015 Jan 22;34(4):506-15. doi: 10.1038/onc.2013.579. Epub 2014 Jan 27.

39.

Detection of extranodal spread in head and neck cancer with [18F]FDG PET and MRI: improved accuracy?

Lodder WL, Vogel WV, Lange CA, Hamming-Vrieze O, Van Velthuysen ML, Pameijer FA, Balm AJ, Van Den Brekel MW.

Q J Nucl Med Mol Imaging. 2015 Sep;59(3):327-35. Epub 2013 Dec 17.

PMID:
24382405
40.

Hsp90 inhibition protects against inherited retinal degeneration.

Aguilà M, Bevilacqua D, McCulley C, Schwarz N, Athanasiou D, Kanuga N, Novoselov SS, Lange CA, Ali RR, Bainbridge JW, Gias C, Coffey PJ, Garriga P, Cheetham ME.

Hum Mol Genet. 2014 Apr 15;23(8):2164-75. doi: 10.1093/hmg/ddt613. Epub 2013 Dec 2.

41.

Tracking progesterone receptor-mediated actions in breast cancer.

Knutson TP, Lange CA.

Pharmacol Ther. 2014 Apr;142(1):114-25. doi: 10.1016/j.pharmthera.2013.11.010. Epub 2013 Nov 26. Review.

42.

PELP1: a review of PELP1 interactions, signaling, and biology.

Girard BJ, Daniel AR, Lange CA, Ostrander JH.

Mol Cell Endocrinol. 2014 Jan 25;382(1):642-651. doi: 10.1016/j.mce.2013.07.031. Epub 2013 Aug 8. Review.

43.

Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.

Regan Anderson TM, Peacock DL, Daniel AR, Hubbard GK, Lofgren KA, Girard BJ, Schörg A, Hoogewijs D, Wenger RH, Seagroves TN, Lange CA.

Cancer Res. 2013 Sep 15;73(18):5810-20. doi: 10.1158/0008-5472.CAN-13-0523. Epub 2013 Aug 8. Erratum in: Cancer Res. 2013 Nov 1;73(21):6538.

44.

A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells.

Hagan CR, Knutson TP, Lange CA.

Nucleic Acids Res. 2013 Oct;41(19):8926-42. doi: 10.1093/nar/gkt706. Epub 2013 Aug 5.

45.

LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling.

Wang X, Abraham S, McKenzie JAG, Jeffs N, Swire M, Tripathi VB, Luhmann UFO, Lange CAK, Zhai Z, Arthur HM, Bainbridge J, Moss SE, Greenwood J.

Nature. 2013 Jul 18;499(7458):306-11. doi: 10.1038/nature12345.

46.

Dynamic regulation of steroid hormone receptor transcriptional activity by reversible SUMOylation.

Knutson TP, Lange CA.

Vitam Horm. 2013;93:227-61. doi: 10.1016/B978-0-12-416673-8.00008-3. Review.

PMID:
23810010
47.

Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.

Diep CH, Charles NJ, Gilks CB, Kalloger SE, Argenta PA, Lange CA.

Cell Cycle. 2013 May 1;12(9):1433-49. doi: 10.4161/cc.24550. Epub 2013 Apr 10.

48.

Can extranodal spread in head and neck cancer be detected on MR imaging.

Lodder WL, Lange CA, van Velthuysen ML, Hauptmann M, Balm AJ, van den Brekel MW, Pameijer FA.

Oral Oncol. 2013 Jun;49(6):626-33. doi: 10.1016/j.oraloncology.2013.02.010. Epub 2013 Mar 20.

49.

Value of MR and CT Imaging for Assessment of Internal Carotid Artery Encasement in Head and Neck Squamous Cell Carcinoma.

Lodder WL, Lange CA, Teertstra HJ, Pameijer FA, van den Brekel MW, Balm AJ.

Int J Surg Oncol. 2013;2013:968758. doi: 10.1155/2013/968758. Epub 2013 Jan 29.

50.

Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular disease.

Robbie SJ, Lundh von Leithner P, Ju M, Lange CA, King AG, Adamson P, Lee D, Sychterz C, Coffey P, Ng YS, Bainbridge JW, Shima DT.

Invest Ophthalmol Vis Sci. 2013 Feb 27;54(2):1490-500. doi: 10.1167/iovs.12-10169.

PMID:
23385800

Supplemental Content

Loading ...
Support Center